However, the potential role of HLA-E as antigen-presenting molecule for tumor-specific CD8+ T cells should be investigated because of the frequent overexpression of HLA-E in some cancers such as melanoma, colorectal carcinoma and cervical adenocarcinoma55–58. This evidence concerns the gene CD8A and neoplasm.